The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis
Abstract
Fibroblast activation protein (FAPalpha) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases. In its dimer form, FAPalpha exhibits gelatinase, collagenase, and DPP activity in vitro. Reactive fibroblasts in healing wounds and stromal fibroblasts associated with epithelial tumors express FAPalpha. Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiology or molecular marker for disease activity. Recently, it has been shown that fibroblast FAPalpha expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (alpha-SMA). In this study, we determine whether FAPalpha expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF. Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung. Immunohistochemical studies were performed using anti-FAPalpha antibody and antibodies against alpha-SMA and CD26 (DPPIV), another member of the DPP family. We found that FAPalpha was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and With a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium. Specifically, FAPalpha was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung. Alveolar/airway epithelium and vascular smooth muscle did not express FAPalpha. This is the first report of FAPalpha expression in IPF and our results suggest that FAPalpha is selectively induced in fibrotic foci, but not in normal or emphysematous lung. Future studies will address whether FAPalpha may be used as a marker for disease activity in IPF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FAP is expressed exclusively in fibrotic loci in the lungs of patients with IPF59”
From A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial (2025) · cites this paper as [59]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.103 · Cited by 2,269
Transforming growth factor beta
Roberts, A. B., & Sporn, M. B. (2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,945
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,807
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Self-citationIredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Sappino, A. P., Schürch, W., & Gabbiani, G. (1990) · PubMed · Cited by 833
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Mechanisms of Myofibroblast Activity and Phenotypic Modulation
Serini, G., & Gabbiani, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4543 · Cited by 592
Park, J. E., Lenter, M., Zimmermann, R., Garin‐Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 591
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 206
Becerril, C., Montaño, M., Cisneros, J., Mendoza-Milla, C., Pardo, A., Ortíz-Quintero, B., Selman, M., & Ramos, C. (2021) · Biomolecules · doi:10.3390/biom11030378 · Cited by 20
Novel tracers for molecular imaging of interstitial lung disease: A state of the art review
Broens, B., Duitman, J., Zwezerijnen, G. J. C., Nossent, E. J., van der Laken, C. J., & Voskuyl, A. E. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103202 · Cited by 20
The expression of proline-specific enzymes in the human lung
Vliegen, G., Raju, T. K., Adriaensen, D., Lambeir, A., & Meester, I. D. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.36 · Cited by 19
Song, P., Pan, Q., Sun, Z. J., Zou, L., & Yang, L. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109830 · Cited by 19
Non-tumoral uptake of 68Ga-FAPI-04 PET: A retrospective study
Qi, N., Wang, H., Wang, H., Ren, S., You, Z., Chen, X., Guan, Y., Xie, F., Hua, F., & Zhao, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.989595 · Cited by 18
Grandi, A., Ferrini, E., Mecozzi, L., Ciccimarra, R., Zoboli, M., Leo, L., Khalajzeyqami, Z., KleinJan, A., Löwik, C. W. G. M., Donofrío, G., et al. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2022 · Cited by 18
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
Henderson, J. M., Zhang, H. E., Polak, N., & Gorrell, M. D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.047 · Cited by 21
Zhang, F.-F., Qiao, Y., Xie, Y., Liu, C., Wu, H., Wu, J., Yu, X., Kong, W., & Zhang, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109237 · Cited by 16
Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis
Singh, M., Sarhan, M. O., Damiba, N. N. L., Singh, A., Villabona-Rueda, A. F., Nino-Meza, O. J., Chen, X., Masias-Leon, Y., Ruiz-Gonzalez, C. E., Ordoñez, A. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58190-x · Cited by 17
The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis
Lavis, P., Garabet, A., Cardozo, A. K., & Bondue, B. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1393778 · Cited by 19
Analysis of gene expression in canine idiopathic pulmonary fibrosis
Krafft, É., Laurila, H. P., Peters, I. R., Bureau, F., Peeters, D., Day, M. J., Rajamäki, M. M., & Clercx, C. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.08.018 · Cited by 16
Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions
Eriksson, O., & Velikyan, I. (2023) · Pharmaceuticals · doi:10.3390/ph16111540 · Cited by 14
Li, W., Yang, L., Wei, F., Chen, Y., Jing, T., Ma, L., Liu, B., Li, Y., Shaoxia, W., Fu, Q., et al. (2015) · Biotechnology Letters · doi:10.1007/s10529-015-1855-8 · Cited by 14
Cai, Z., Guo, H., Qian, J., Liu, W. Q., Li, Y., Liang, Y., Zhou, Y., Lin, R., Xie, X., Yang, Q., et al. (2022) · PeerJ · doi:10.7717/peerj.13775 · Cited by 13
Keane, F. M., Chowdhury, S., Yao, T.-W., Nadvi, N. A., Gall, M. G., Chen, Y., Osborne, B., de Ribeiro, A. J. V., Church, W. B., McCaughan, G. W., et al. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733151-00118 · Cited by 13
Kawashima, S., Yoshida, D., Yoshioka, T., Ogasawara, A., Fujita, K., Yanagiya, M., Nagano, M., Konoeda, C., Hino, H., Kitano, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12665-9 · Cited by 13
Assessment of pulmonary fibrosis induced by paraquat using Al18F-NODA-FAPI-04 PET/CT
Song, C., Liu, Z.-F., Wang, P., Su, X., & Lu, Y. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03327-3 · Cited by 13
Fibroblast activation protein is dispensable in the anti-influenza immune response in mice
Tan, S., Chowdhury, S., Polak, N., Gorrell, M. D., & Weninger, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171194 · Cited by 13
The Role and Application of Fibroblast Activating Protein
Zhang, X.-L., Wang, X., Qian, J., Yang, W.-J., Xu, H., Xu, X.-D., & Zhang, G. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230530095305 · Cited by 12
Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Simaeys, G. V., Lacroix, S., Passon, N., Heymbeek, C. V., Maeseneire, C. D., Allard, J., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02556-6 · Cited by 13
Fang, Q., Liu, S., Cui, J., Zhao, R., Han, Q., Hou, P., Li, Y., Lv, J., Zhang, X., Luo, Q., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.920766 · Cited by 13
Fibroblast Activation Protein α
Gorrell, M. D., & Park, J. E. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00750-x · Cited by 12
Li, M., Deng, Z., Xie, C., Chen, J., Yuan, Z., Rahhal, O., & Tang, Z. (2023) · Oral Diseases · doi:10.1111/odi.14602 · Cited by 11
Enhanced Detection of Early Pulmonary Fibrosis Disease Using 68Ga-FAPI-LM3 PET
Chen, J., Luo, D., Dai, Y., Zhou, Y., Pang, Y., Wu, H., Sun, L., Su, G., Lin, Q., Zhao, L., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00405 · Cited by 10
Sakir, M., Ballal, S., Rastogi, S., Yadav, M. P., Roesch, F., Chandekar, K. R., Priyanka, G. B., Tripathi, M., Dhiman, A., Taggar, M., et al. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005697 · Cited by 12
Jafari, E., Juweid, M. E., Bahtouee, M., Pourbehi, M. R., Esmaeilinejad, K., Jokar, N., & Assadi, M. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.07.034 · Cited by 10
Köchel, R., Wagner, S., Schwegmann, K., Schäfers, M. A., Breyholz, H., & Wünsch, B. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117513 · Cited by 9
Diagnostic Value of 18F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
Qin, X., Wang, S., Liu, X., Duan, J., Cheng, K., Mu, Z., Jia, J., Wei, Y., & Yuan, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.879281 · Cited by 9
Taboła, R., Zaremba-Czogalla, M., Baczyńska, D., Cirocchi, R., Stach, K., Grabowski, K., & Augoff, K. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2793 · Cited by 10
Liu, Z., Zhou, H., Li, P., Wang, Z., Tu, T., Ezzi, S. H. A., Kota, V. G., Abdulla, M. H. A. H., Alhaskawi, A., Dong, Y., et al. (2023) · The American Journal of Sports Medicine · doi:10.1177/03635465231208843 · Cited by 8
Rizzoli, E., meeûs, C. D., Fastrès, A., Roels, É., Janssen, P., Puré, E., Garigliany, M.-M., Marichal, T., & Clercx, C. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1416124 · Cited by 8
Self-citationMechanisms on How Matricellular Microenvironments Sustain Idiopathic Pulmonary Fibrosis
Jones, N., Rahar, B., Bernau, K., Schulte, J. J., Campagnola, P. J., & Brasier, A. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115393 · Cited by 8
Hua, E., Xu, D., Chen, H., Zhang, S., Feng, J., & Xu, L. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1158 · Cited by 7
Narain, R., Nessler, I., Richardson, P. L., Erickson, J. E., Wang, Y., Ferri, J., Knight, H., Bryant, S. H., Phillips, L. A., Zhang, L., et al. (2024) · npj Imaging · doi:10.1038/s44303-024-00028-0 · Cited by 8
Huang, X., Khoong, Y., Han, C., Su, D., Ma, H., Gu, S., Li, Q., & Zan, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.694605 · Cited by 8
Juengling, F. D., Maldonado, A., Wuest, F. R., & Schindler, T. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.568959 · Cited by 7
Montesi, S. B., & Horowitz, J. C. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202208-1638ed · Cited by 7
Christian, L., Yilmaz, H., Ruwisch, J., Giercke, L., Seeliger, B., Kamp, J. C., Bayraktar, S., Ewen, R., Graalmann, T., Fuge, J., et al. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamaf089 · Cited by 8
Zhang, K., Yue, B., Duan, X., Chen, W., Dai, X., Chen, Y., Li, X., & Lü, J. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154462 · Cited by 6
Bendre, S., Zhang, Z., Colpo, N., Zeisler, J., Wong, A. A. W. L., Bénard, F., & Lin, K. (2023) · Molecules · doi:10.3390/molecules28083481 · Cited by 6
Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer
Mathieson, L., O’Connor, R. A., Stewart, H. L., Shaw, P. A., Dhaliwal, K., Williams, G. O. S., Megía-Fernández, A., & Akram, A. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834350 · Cited by 6
Beck, M., Kuwert, T., Atzinger, A., Gerner, M., Hartmann, A., Saake, M., Uder, M., Neurath, M. F., & Atreya, R. N. (2024) · Visceral Medicine · doi:10.1159/000542160 · Cited by 5
Physiological Uptake of 68Ga-FAPI-04 in Female Reproductive System
Mu, J., Zhang, Y., Xia, Y., Zhou, Y., Gan, R., Xiang, Q., Su, M., & Jia, Z. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-02011-6 · Cited by 5
Sviridenko, A., di Santo, G., & Virgolini, I. J. (2023) · PET Clinics · doi:10.1016/j.cpet.2023.02.004 · Cited by 5
Prior, T. S., Hoyer, N., Davidsen, J. R., Shaker, S. B., Hundahl, M. P., Lomholt, S., Deleuran, B. W., Bendstrup, E. M., & Kragstrup, T. W. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13392 · Cited by 5
Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time?
ARGOLLO, M. C., Gilardi, D., Roda, G., Fiorino, G., Peyrin‐Biroulet, L., & Danese, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190308100844 · Cited by 5
The Role of Activated Stromal Cells in Fibrotic Foci Formation and Reversion
Basalova, N. A., Vigovskiy, M. A., Popov, V. S., Lagereva, E., Grigorieva, O., & Efimenko, A. Y. (2024) · Cells · doi:10.3390/cells13242064 · Cited by 4
Developing PI3K Inhibitors for Respiratory Diseases
Fagone, E., Fruciano, M., Gili, E., Sambataro, G., & Vancheri, C. (2022) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-06566-8_19 · Cited by 4
Dalapati, T., Wang, L., Jones, A. G., Cardwell, J., Konigsberg, I. R., Bossé, Y., Sin, D. D., Timens, W., Hao, K., Yang, I. V., et al. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100410 · Cited by 5
FAP expression dynamics and role in silicosis: Insights from epidemiological and experimental models
Deng, X., Cheng, Z., Li, Y., Duan, M., Qi, J., Hao, C., & Yao, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124311 · Cited by 4
Zhu, M., Xu, F., Zhu, L., Chen, Q., Jiang, X., Pan, C., Yu, W., & Zhang, H. (2025) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001735 · Cited by 3
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases
Jenabi, E., Hotta, M., Atzinger, A., Volkmann, E., Jung, T., Bailly, M., Pirich, C., Calais, J., Kuwert, T., & Beheshti, M. (2026) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2026.04.003 · Cited by 3
Introduction of Z-GP scaffold into procarbazine reduces spermatoxicity and myelosuppression
Wang, R., Zhang, C., Zheng, C., Li, H., Xie, X., Jin, Y., Liu, Z., & Chen, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.011 · Cited by 3
Tolstoluzhinskaya, A., Basalova, N. A., Karagyaur, M. N., & Efimenko, A. Y. (2025) · Genes and Cells · doi:10.17816/gc636876 · Cited by 2
GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosis
Broens, B., van der Laken, C. J., Radonic, T. R., Nossent, E. J., Manz, X. D., Mulder, D. J., Al-Adwi, Y., Gan, C. T., Timens, W., Voskuyl, A. E., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03363-x · Cited by 2
Growing Pains: GH-induced Fibrosis Across Multiple Organs in bGH Mice
Lach, G., Brown, F. N., Lee, A. E., Kington, Z. A., Sanderson, A., Cronin, R. N., Young, J. A., Bæk, A., List, E. O., Kopchick, J. J., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf170 · Cited by 2
Controversies of [68Ga]Ga-FAPI-46 and 2-[18F]FDG findings in metastatic melanoma
Novruzov, F., Mehdi, E., Orucova, N., Aliyeva, G., Valla, F., Mammadzada, H., Shahin, D., & Aliyev, J. A. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06444-5 · Cited by 2
Kim, S., & Jang, Y. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114230 · Cited by 2
Clinical, Cellular and Serologic Biomarkers of Intestinal Fibrosis
Sabatino, A. D., & Giuffrida, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_12 · Cited by 2
Kimura, T., Akazawa, T., Mizote, Y., Nakamura, H., Sakaue, M., Maniwa, T., Shintani, Y., Honma, K., Tahara, H., & Okami, J. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02507-1 · Cited by 2
Broens, B., van der Laken, C. J., Simons, I. A., Dekker, T., Duitman, J., & Voskuyl, A. E. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03656-y · Cited by 1
Metformin promotes wound healing in senescent fibroblasts by regulating SIRT1 and FAP-α
Çetinavcı, D., Yaşar, V., Yiğittürk, G., & Elbe, H. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02431-z · Cited by 2
GH replacement therapy in adults stimulates fibroblast activation protein-α activity
Bæk, A., Pedersen, A. K. N., Billeskov, T. B., Dollerup, O. L., Arlien-Søborg, M. C., Jessen, N., Bjerre, M., & Jørgensen, J. O. L. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf244 · Cited by 1
Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Tutunaru, A. C., Garigliany, M.-M., Gérardy, M., Bolen, G., Withofs, N., Gendron, T., et al. (2026) · The Veterinary Journal · doi:10.1016/j.tvjl.2026.106565 · Cited by 1
Growth hormone causes reversible fibrosis in muscle and fat: a study in patients with acromegaly
Bæk, A., Arlien-Søborg, M. C., Pedersen, A. K. N., Dal, J., Madsen, M. A., Høgild, M. L., Berryman, D. E., Kopchick, J. J., Pedersen, S. B., Bjerre, M., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag032 · Cited by 1
Hu, X., Han, C., Zhang, M., Jia, J., Mu, Z., Fu, Z., Qiao, K., Yu, J., & Wei, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-14236-3 · Cited by 1
Lange, T. C., Renko, A., Flierl, U., Ademmer, F. B., Bauersachs, J. K., Christiansen, H., & Tillmanns, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02998-y · Cited by 1
Dalapati, T., Wang, L., Jones, A. G., Cardwell, J., Konigsberg, I. R., Bossé, Y., Sin, D. D., Timens, W., Hao, K., Yang, I. V., et al. (2024) · medRxiv · doi:10.1101/2024.07.13.24310305 · Cited by 1
Abikar, A., Mohammad, M. M. S., Athalye, R. R., Nadig, N., Tamboli, N., Babu, V., Keshavamurthy, R., & Ranganathan, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.09.627457 · Cited by 1
Liu, C., Guo, Z., Shi, Y. W., Wu, Z., Xiang, Z., Tian, Y., Liang, G., Qin, Z., Wang, R., Li, S., et al. (2025) · medRxiv · doi:10.1101/2025.03.29.25324444 · Cited by 1
Wai, S., Kang, S., Li, N., Dai, Y., Lavoie, T. L., Strzalka, J. W., Sutyak, S., Weires, M., Fu, T., Wang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.31.683260 · Cited by 1
Radioligand as a Unique Rising Modality for Cancer Diagnosis and Treatment
Jheng, M., Wang, X., Li, P., & Liu, F. (2025) · Peptide Science · doi:10.1002/9781119824701.ch11 · Cited by 1
Stromal Cells and Tumor Milieu: PDGF et al.
Jacob, M., & Puré, E. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_14
Self-citationHeightman, M., Ort, T., de Garavilla, L., Kilgore, K., & Laurent, G. J. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0157-7_7
Analysis of cytokine expression in breast cancer
Hartmann, M. C. (2014) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17738
Ongstad, E. L. (2015) · TigerPrints (Clemson University)
Lewis, K. (2008) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70640-6
Dipeptidyl Peptidases: Substrates and Therapeutic Targeting in Human Health and Disease
Wilson, C. H., & Abbott, C. A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733151-00001
The pleomorphic role of stromal cells in the formation and maintenance of tertiary lymphoid organs
Campos, J. D. D. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Poocza, L. (2020) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/40592
Macrophage-matrix interactions: orchestrating the fibrotic response?
Vasse, G. F. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.170746933
Chung, L., Franch, X., & Maiden, N. (2005)
Lewis, K. L. (2008) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70625-x
Munger, J. S., & Rom, W. N. (2008) · Molecular pathology library · doi:10.1007/978-0-387-72430-0_46
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironmentPreprint
Hartmann, K. P., van Gogh, M., Freitag, P. C., Kast, F., Nagy‐Davidescu, G., Borsig, L., & Plückthun, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.19.520931
Wang, L. S., Lo, A., Scholler, J., Sun, J., Majumdar, R. S., Kapoor, V., Antzis, M., Cotner, C. E., Johnson, L. A., Durham, A. C., et al. (2023) · doi:10.1158/2326-6066.c.6548249.v1
Self-citationHu, X., Han, C., Zhang, M., Mu, Z., Fu, Z., Ren, J., Qiao, K., Jia, J., Yu, J., Yuan, S., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.06.2323
Danilova, N. V., Basalova, N. A., Oleynikova, N. A., Kelly, E., Zayratyants, O. V., & Efimenko, A. Y. (2024) · Russian Journal of Archive of Pathology · doi:10.17116/patol2024860615
Wegrzyniak, O., Ekbom, E., Ellingsen, J., Eriksson, O., Lubberink, M., Malinovschi, A., Sigfridsson, J., Velikyan, I., Wilson, V., Emilsson, Ö. I., et al. (2025) · medRxiv · doi:10.1101/2025.06.18.25329561
Rymenant, Y. V., de Groot, A., Dirkx, L., Verhulst, E., Loose, J. D., Pintelon, I., Verhezen, T., Waele, J. D., Thys, S., Wever, O. D., et al. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf103 · Cited by 1
Ahmed, S. W., Gogoi, D., Forde, L., Niu, M., Baird, R., McCarthy, C., Keane, M. P., McGrath, E. E., & Reeves, E. P. (2025) · Journal of Innate Immunity · doi:10.1159/000547814
A DDR2-targeted PET tracer images activated fibroblasts in early pulmonary fibrosisPreprint
Chen, X., Lai, Y., Yang, P., Li, G., Hu, G., Rao, J.-H., Shi, M., Luo, Q., Chen, Z., Jiang, J., et al. (2025) · medRxiv · doi:10.1101/2025.11.26.25341068
Lavis, P., Pingitore, J., Doumont, G., Garabet, A., Simaeys, G. V., Lacroix, S., Passon, N., Heymbeek, C. V., Maeseneire, C. D., Allard, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26632282
Liu, C. L., Guo, Z., Shi, Y., Wu, Z., Xiang, Z., Yao, T., Liang, G., Qin, Z., Wang, R., Li, L., et al. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01364-x
Ma, Y., Zhang, N., Wu, S., He, J., Jiang, Y., Qin, M., Feng, H., Li, W., & Hou, Y. (2026) · Nanoscale · doi:10.1039/d5nr05495h
Synthese et evaluation de traceurs peptidiques heterobivalents pour l’imagerie moleculaire
Bailly, T. (2022) · theses.fr (ABES) · doi:10.70675/ff7dcc7dzaeecz4574z851bzb468baa1e15b
Quantitative Thoracic Imaging with Nuclear Medicine
Zeman, M. N., Auer, B. R., Mohammadi, S., Jiang, F., Kwatra, N. S., & Ng, T. S. C. (2026) · Springer eBooks · doi:10.1007/978-3-032-14103-3_25
New treatment approaches for fibrosing skin disorders
Moinzadeh, P., Gabrielli, A., & Krieg, T. M. (2026) · SKINdeep · doi:10.1553/skindeep.2026.189305
Choi, S., Shim, M., Min, K., Noh, Y., Kim, H. S., Kim, K. S., Jung, U. S., Lee, K. S., & Kwon, M. J. (2026) · Pathobiology · doi:10.1159/000553452
Metadata
- Authors
- Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A.-L. A., & Puré, E.
- Affiliations
- The Wistar Institute (US)
- SUNY Upstate Medical University (US)
- Corresponding author
- Acharya, Pinak S.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 37
- Issue
- 3
- Pages
- 352-360
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W2018096662
- Cited by
- 204
- References
- 38
- Citations by year
- 2026: 13 · 2025: 25 · 2024: 16 · 2023: 25 · 2022: 20 · 2021: 11 · 2020: 11 · 2019: 5 · 2018: 5 · 2017: 14 · 2016: 9 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 6
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Pathology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P50HL067663, P50-HL67663)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- fibroblast activation protein, idiopathic pulmonary fibrosis, serine protease, dipeptidyl peptidase, tissue remodeling, fibroblast foci, alpha-smooth muscle actin, CD26, emphysema, pulmonary fibrosis, disease markers
- MeSH terms
- Fibroblast Activation Protein Alpha, Antigens, Surface, Emphysema, Female, Fibroblasts, Humans, Immunoenzyme Techniques, Lung, Male, Membrane Proteins, Middle Aged, Endopeptidases, Pulmonary Fibrosis, Serine Endopeptidases, Gelatinases, Dipeptidyl Peptidase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review